Dolutegravir sodium is an organic sodium salt that is the monosodium salt of dolutegravir. Used for treatment of HIV-1. Among its listed roles, it functions as a HIV-1 integrase inhibitor. It includes a dolutegravir(1-). It is grouped under the following drug class(es): HIV-1 Integrase Inhibitors. Its therapeutic use is listed as antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dovato and Tivicay. Its PubChem CID is 46216142.
Dolutegravir sodium
| CAS No | 1051375-19-9 |
|---|---|
| Molecular Formula | C20H18F2N3NaO5 |
| Molecular Weight | 441.4 g/mol |
| Synonyms | sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dolutegravir sodium is an organic sodium salt that is the monosodium salt of dolutegravir. Used for treatment of HIV-1. Among its listed roles, it functions as a HIV-1 integrase inhibitor.
The listed CAS number is 1051375-19-9.
The listed molecular formula is C20H18F2N3NaO5.
The listed molecular weight is 441.4 g/mol.
sodium (3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate.
The source lists Dovato and Tivicay.